Apellis Pharmaceuticals, Inc. (BIT:1APLS)
19.01
0.00 (0.00%)
At close: Oct 10, 2025
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of €2.73 billion as of October 10, 2025. Its market cap has decreased by -18.24% in one year.
Market Cap
2.73B
Enterprise Value
2.81B
Revenue
642.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
€19.01
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from 593.77M to 2.73B, an increase of 359.64%. That is a compound annual growth rate of 21.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 2.73B | -28.82% |
Dec 31, 2024 | 3.83B | -40.26% |
Dec 29, 2023 | 6.42B | 19.95% |
Dec 30, 2022 | 5.35B | 32.19% |
Dec 31, 2021 | 4.05B | 14.29% |
Dec 31, 2020 | 3.54B | 103.16% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Nov 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UniCredit | 97.20B |
Intesa Sanpaolo | 95.74B |
Enel SpA | 84.55B |
Ferrari | 61.24B |
Assicurazioni Generali | 50.22B |
Eni S.p.A. | 45.35B |
Leonardo S.p.a. | 30.49B |
Poste Italiane | 26.45B |